PMID- 26920939 OWN - NLM STAT- MEDLINE DCOM- 20180205 LR - 20181113 IS - 1615-2573 (Electronic) IS - 0910-8327 (Linking) VI - 31 IP - 12 DP - 2016 Dec TI - Clinical significance of endomyocardial biopsy in conjunction with cardiac magnetic resonance imaging to predict left ventricular reverse remodeling in idiopathic dilated cardiomyopathy. PG - 1960-1968 AB - Endomyocardial biopsy (EMB) and cardiac magnetic resonance (CMR) are useful modalities to study the characteristics of myocardial tissue. However, the prognostic impact of both diagnostic tools to predict subsequent left ventricular reverse remodeling (LVRR) has not been well elucidated. A total of 187 consecutive patients with idiopathic dilated cardiomyopathy (IDCM) who were treated by optimal pharmacotherapy (OPT) and underwent EMB of the LV wall were investigated. The myocardial specimens were semiquantitatively evaluated measuring cardiomyocyte degeneration (CD), interstitial fibrosis (IF), and hypertrophy. In addition, late gadolinium enhancement (LGE)-CMR was performed in 78 (48 %) patients. Seventy-eight (48 %) patients developed LVRR, defined as a >/=10 % increase in LV ejection fraction with a >/=10 % decrease in indexed LV end-diastolic dimension at 12 months after OPT. Multivariate regression analysis revealed that CD (P = 0.003), but not IF (P = 0.320), was an independent predictor of LVRR. In the patients with not only EMB but also CMR, the CD score and LGE area were independent predictors of LVRR (odds ratios/P values 0.268/0.010, 0.855/<0.001, respectively). The patients with mild CD and negative LGE had a better achievement rate of LVRR than those with severe CD and positive LGE (74 vs. 19 %). A combination of CD score on EMB and LGE-CMR is useful to predict subsequent LVRR in IDCM patients. FAU - Ishii, Shunsuke AU - Ishii S AD - Department of Cardiovascular Medicine, Kitasato University School of Medicine, 1-15-1 Kitasato, Minami-ku, Sagamihara, Kanagawa, 252-0374, Japan. sishii@med.kitasato-u.ac.jp. FAU - Inomata, Takayuki AU - Inomata T AD - Department of Cardiovascular Medicine, Kitasato University School of Medicine, 1-15-1 Kitasato, Minami-ku, Sagamihara, Kanagawa, 252-0374, Japan. FAU - Fujita, Teppei AU - Fujita T AD - Department of Cardiovascular Medicine, Kitasato University School of Medicine, 1-15-1 Kitasato, Minami-ku, Sagamihara, Kanagawa, 252-0374, Japan. FAU - Iida, Yuichiro AU - Iida Y AD - Department of Cardiovascular Medicine, Kitasato University School of Medicine, 1-15-1 Kitasato, Minami-ku, Sagamihara, Kanagawa, 252-0374, Japan. FAU - Ikeda, Yuki AU - Ikeda Y AD - Department of Cardiovascular Medicine, Kitasato University School of Medicine, 1-15-1 Kitasato, Minami-ku, Sagamihara, Kanagawa, 252-0374, Japan. FAU - Nabeta, Takeru AU - Nabeta T AD - Department of Cardiovascular Medicine, Kitasato University School of Medicine, 1-15-1 Kitasato, Minami-ku, Sagamihara, Kanagawa, 252-0374, Japan. FAU - Yanagisawa, Tomoyoshi AU - Yanagisawa T AD - Department of Cardiovascular Medicine, Kitasato University School of Medicine, 1-15-1 Kitasato, Minami-ku, Sagamihara, Kanagawa, 252-0374, Japan. FAU - Naruke, Takashi AU - Naruke T AD - Department of Cardiovascular Medicine, Kitasato University School of Medicine, 1-15-1 Kitasato, Minami-ku, Sagamihara, Kanagawa, 252-0374, Japan. FAU - Mizutani, Tomohiro AU - Mizutani T AD - Department of Cardiovascular Medicine, Kitasato University School of Medicine, 1-15-1 Kitasato, Minami-ku, Sagamihara, Kanagawa, 252-0374, Japan. FAU - Koitabashi, Toshimi AU - Koitabashi T AD - Department of Cardiovascular Medicine, Kitasato University School of Medicine, 1-15-1 Kitasato, Minami-ku, Sagamihara, Kanagawa, 252-0374, Japan. FAU - Takeuchi, Ichiro AU - Takeuchi I AD - Department of Cardiovascular Medicine, Kitasato University School of Medicine, 1-15-1 Kitasato, Minami-ku, Sagamihara, Kanagawa, 252-0374, Japan. FAU - Ako, Junya AU - Ako J AD - Department of Cardiovascular Medicine, Kitasato University School of Medicine, 1-15-1 Kitasato, Minami-ku, Sagamihara, Kanagawa, 252-0374, Japan. LA - eng PT - Journal Article DEP - 20160226 PL - Japan TA - Heart Vessels JT - Heart and vessels JID - 8511258 RN - 0 (Cardiovascular Agents) RN - 0 (Contrast Media) SB - IM MH - Adult MH - Aged MH - *Biopsy MH - Cardiomyopathy, Dilated/*diagnostic imaging/drug therapy/*pathology/physiopathology MH - Cardiovascular Agents/therapeutic use MH - Chi-Square Distribution MH - Contrast Media/administration & dosage MH - Female MH - Humans MH - Kaplan-Meier Estimate MH - Logistic Models MH - *Magnetic Resonance Imaging MH - Male MH - Middle Aged MH - Multivariate Analysis MH - Myocardium/*pathology MH - Odds Ratio MH - Predictive Value of Tests MH - Retrospective Studies MH - Treatment Outcome MH - *Ventricular Function, Left/drug effects MH - *Ventricular Remodeling/drug effects OTO - NOTNLM OT - Cardiac magnetic resonance OT - Endomycardial biopsy OT - Idiopathic dilated cardiomyopathy OT - Left ventricular reverse remodeling EDAT- 2016/02/28 06:00 MHDA- 2018/02/06 06:00 CRDT- 2016/02/28 06:00 PHST- 2015/09/30 00:00 [received] PHST- 2016/02/05 00:00 [accepted] PHST- 2016/02/28 06:00 [pubmed] PHST- 2018/02/06 06:00 [medline] PHST- 2016/02/28 06:00 [entrez] AID - 10.1007/s00380-016-0815-0 [pii] AID - 10.1007/s00380-016-0815-0 [doi] PST - ppublish SO - Heart Vessels. 2016 Dec;31(12):1960-1968. doi: 10.1007/s00380-016-0815-0. Epub 2016 Feb 26.